Fate Therapeutics Inc.

NASDAQ: FATE · Real-Time Price · USD
1.24
-0.04 (-3.13%)
At close: May 01, 2025, 3:59 PM
1.25
1.21%
After-hours: May 01, 2025, 07:58 PM EDT

Fate Therapeutics Revenue

Fate Therapeutics reported an annual revenue of $13.63M, reflecting a -78.55% growth. For the quarter ending December 31, 2024, Fate Therapeutics generated $1.86M in revenue.
Revenue (ttm)
$13.63M
Revenue Growth
-78.55%
Price / Sales Ratio
13.76
Revenue / Employee
$75.31K
Employees
181
Market Cap
141.54M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 13.63M -78.55%
Dec 31, 2023 63.53M -34.03%
Dec 31, 2022 96.3M +72.44%
Dec 31, 2021 55.85M +77.66%
Dec 31, 2020 31.43M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.